|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Quinapril#Patient Counseling Information]] |
| {{Quinapril}}
| |
| {{CMG}}; {{AE}} {{AM}}
| |
| | |
| ==Information for Patients==
| |
| | |
| ====Pregnancy====
| |
| | |
| Female patients of childbearing age should be told about the consequences of exposure to ACCUPRIL during pregnancy. Discuss treatment options with women planning to become pregnant. Patients should be asked to report pregnancies to their physicians as soon as possible.
| |
| | |
| ====Angioedema====
| |
| | |
| [[Angioedema]], including laryngeal edema can occur with treatment with ACE inhibitors, especially following the first dose. Patients should be so advised and told to report immediately any signs or symptoms suggesting [[angioedema]] (swelling of face, extremities, eyes, lips, tongue, difficulty in swallowing or breathing) and to stop taking the drug until they have consulted with their physician.
| |
| | |
| ====Symptomatic hypotension====
| |
| | |
| Patients should be cautioned that [[lightheadedness]] can occur, especially during the first few days of ACCUPRIL therapy, and that it should be reported to a physician. If actual syncope occurs, patients should be told to not take the drug until they have consulted with their physician.
| |
| | |
| All patients should be cautioned that inadequate fluid intake or excessive perspiration, [[diarrhea]], or [[vomiting]] can lead to an excessive fall in blood pressure because of reduction in fluid volume, with the same consequences of lightheadedness and possible syncope.
| |
| | |
| Patients planning to undergo any surgery and/or anesthesia should be told to inform their physician that they are taking an ACE inhibitor.
| |
| | |
| ====Hyperkalemia====
| |
| | |
| Patients should be told not to use potassium supplements or salt substitutes containing potassium without consulting their physician.
| |
| | |
| ====Neutropenia====
| |
| | |
| Patients should be told to report promptly any indication of infection (eg, sore throat, fever) which could be a sign of [[neutropenia]].
| |
| | |
| NOTE: As with many other drugs, certain advice to patients being treated with ACCUPRIL is warranted. This information is intended to aid in the safe and effective use of this medication. It is not a disclosure of all possible adverse or intended effects.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ACCUPRIL (QUINAPRIL HYDROCHLORIDE) TABLET, FILM COATED [PARKE-DAVIS DIV OF PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63cf5651-d52c-4d27-9fd4-ed9cd9724dff | publisher = | date = | accessdate = }}</ref>
| |
| | |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |